Latest papers

Genome sequencing reveals a phage in Helicobacter pylori.

Physical activity and hematologic cancer prevention.

Pediatric rheumatology: JIA, treatment and possible risk of malignancies.

Physical activity and hematological cancer survivorship.

Lymphomatoid granulomatosis: insights gained over 4 decades.

Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity.

[Molecular abnormalities in lymphomas].

MRI in diagnosis of orbital masses.

Occupational exposure to ethylene oxide and risk of lymphoma.

[Treatment of primary central nervous system lymphoma: recent advances].

DNA vaccination strategies for anti-tumour effective gene therapy protocols.

[Molecular markers in hematology and oncology].

[Unexpected peaks in serum electrophoresis].

[Swollen lymph node: infectious disease or malignancy].

What is your diagnosis? Lymphoma.

Quantitative analysis of mRNA for 10 different drug resistance factors in dogs with lymphoma.

Measuring the “Unmeasurable”

Doxorubicin and cyclophosphamide for the treatment of canine lymphoma: a randomized, placebo-controlled study.

Regulatory T cells control macrophage accumulation and activation in lymphoma.

Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.